Clinical Trial Update: Analysis of Olaparib Response in Patients With BRCA1 and/or 2 Promoter Methylation Diagnosed of Advanced Breast Cancer [Phase 2]

View source ↗

Summary

This Clinical Trials Update reports Phase 2 results for olaparib in patients with BRCA1/2 promoter methylation and advanced breast cancer. Results were posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Lynparza (olaparib)

Snippet

Sponsor: Spanish Breast Cancer Research Group | Conditions: Advanced Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-05-01